JPML Declines To Combine Chemed Shareholder Suits
The U.S. Judicial Panel on Multidistrict Litigation on Thursday declined to combine two shareholder derivative actions accusing Chemed Corp. and its executives of submitting various improper and ineligible claims to Medicare...To view the full article, register now.
Already a subscriber? Click here to view full article